To cite this paper use one of the standards below:
The development of antitumor agents remains a major focus in research. Among the most promising candidates, chalcogen-containing organic compounds have attracted considerable attention due to their antiproliferative properties. Selenium-containing derivatives have demonstrated greater biological activity than their sulfur analogs.[1–3]
In this study, selenide-substituted imidazolium cations, were synthesized from imidazolium ionic liquids using methyl iodide or similar alkylating agents, affording the products in 70–85% yields.
The cytotoxic activity of the compounds was evaluated using the MTT assay against the human tumor cell lines MDA-MB-231 and A549, as well as the non-tumorigenic MCF-10A cell line.[4] The selenides exhibited potent antiproliferative activity toward both tumor cell lines evaluated, with IC₅₀ values of approximately 5 µM, whereas the IC₅₀ for MCF-10A, a non-tumorigenic cell line, was approximately 25 µM, indicating promising selectivity. Overall, these findings identify selenide-substituted imidazolium cations as promising candidates for the development of new antitumor agents.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper